Shionogi

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Forbes

GSK wins priority status for new HIV drug in U.S.

GSK wins priority status for new HIV drug in U.S.

Reuters

Shionogi applies for HIV drug approval in U.S., Europe

Shionogi applies for HIV drug approval in U.S., Europe

Reuters

Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Glaxo-Pfizer HIV Drug Helps Hard-to-Treat Patients

Bloomberg

Shionogi enters into license agreement with Janssen for Alzheimer's treatment

Shionogi enters into license agreement with Janssen for Alzheimer's treatment

Equities.com

Shionogi to take 10 pct stake in GSK, Pfizer HIV drug venture

Shionogi to take 10 pct stake in GSK, Pfizer HIV drug venture

Reuters

Can These 3 Companies Take Down Gilead?

Can These 3 Companies Take Down Gilead?

Motley Fool

Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test

Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla In Test

Bloomberg

News

Mylan Pharma Nisoldipine ER tablets gets FDA approval

Pharmaceutical Business Review

News

Shionogi Needs Sales Reps, But No Reps Need Apply

Pharmalot